CompletedEarly Phase 1

Induction of Abortion in the Second Trimester

Egypt40 participantsStarted 2022-12-01

Plain-language summary

To compare between the effects of misoprostol with hyoscine N-butyl bromide and misoprostol alone on shortening the time of abortion induction in the second trimester.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Abortion between 13-24 weeks with positive fetal pulsation due to congenital fetal malformations, severe preeclampsia, and maternal life-threatening conditions.
✓. Women have up to two cesarean sections.

Exclusion criteria

✕. Abortion between 13-24 weeks with no fetal pulsation
✕. Women who have had two or more caesarean sections.
✕. Multiple pregnancies
✕. Uterine anomalies, such as septate and didelphis uteri.

What they're measuring

Efficacy of hyoscine as an adjuvant treatment in second trimester abortion

Timeframe: Baseline

Trial details

NCT IDNCT06207539

SponsorAin Shams Maternity Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-30

View on ClinicalTrials.gov More Abortion, Second Trimester trials